The protease inhibitor-associated lipodystrophy syndrome is associated with the external changes of peripheral wasting and central fat accumulations. The syndrome may vary from minimal to severe. This study was done at St. Vincent's Hospital and the University of New South Wales in Sydney, Australia.
